All In MedTech

Device Trial Radar · NCT07571473

CoreSys Monitoring for Intraoperative Stress Management in Abdominal Hysterectomy

CoreSys Monitoring for Intraoperative Stress Management in Abdominal Hysterectomy: A Randomized Controlled Trial

Last checked: Nov 19, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

30

Planned (sponsor's estimate)

Start

Jan 8, 2025

Primary completion

Mar 31, 2027

Study completion Mar 31, 2027

Sponsor

Lead sponsor
Hospital Provincial de RosarioAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Coresys Health
First posted
May 6, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
Female only, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This randomized controlled trial evaluates whether intraoperative guidance using the CoreSys monitor reduces the surgical stress response in patients undergoing elective open abdominal hysterectomy. Surgical stress involves complex hemodynamic, endocrine, and inflammatory responses that may negatively impact postoperative recovery. Patients will be randomized to either anesthesia guided by conventional clinical and hemodynamic parameters or anesthesia additionally guided by CoreSys-derived indices of consciousness, nociception, and stress activity. The primary objective is to assess whether CoreSys-guided anesthesia attenuates stress biomarkers, including interleukin-6 (IL-6), cortisol and glycemia.

Conditions

  • Surgical Stress Response
  • Inflammation
  • Anesthesia
  • Perioperative Care

Interventions

  • propofolDrug

    Intravenous administration of propofol using target-controlled infusion (TCI) based on the Marsh pharmacokinetic model for induction and maintenance of general anesthesia.

  • CoreSys MonitorDevice

    A non-invasive monitoring device that integrates electroencephalographic and autonomic signals to assess hypnotic level, nociception, and intraoperative stress indices.

  • Remifentanil (Target-Controlled Infusion)Drug

    Intravenous administration of remifentanil using target-controlled infusion (TCI) based on the Minto pharmacokinetic model for intraoperative analgesia.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in interleukin-6 (IL-6) levelsTime frame: Baseline (pre-induction), end of surgery, and 24 hours postoperatively
  2. Change in cortisol levelsTime frame: Baseline (pre-induction), end of surgery, and 24 hours postoperatively
  3. Change in blood glucose levelsTime frame: Baseline (pre-induction), end of surgery, and 24 hours postoperatively

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Hospital Provincial de Rosario

    Rosario, Santa Fe Province, Argentina · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.